Breast Cancer

We build your team of breast cancer experts based on your needs, providing personalized, compassionate care.

First, we identify the specific type of breast cancer using microscopic analysis, genetic testing, and imaging. Then, we create an individualized treatment plan for you. At the Breast Cancer Center, part of NYU Langone’s Perlmutter Cancer Center, our experts provide the most advanced treatments, such as breast-conserving surgery and targeted drugs, and our researchers evaluate promising new treatments for breast cancer in clinical trials.

We offer comprehensive support services including fertility preservation counseling, psychological support, and integrative therapies.

We counsel women who are at high risk for developing breast cancer, and our experts frequently provide second opinions.

Clinical Trials and Research Studies

Phase 2

A Global Phase 2 Study of ARX788 in HER2-positiveMetastatic Breast Cancer Patients Whose Disease is Resistant or Refractory to T-DM1 and/or T-DXd and/or Tucatinib-containing Regimens

Learn More

Phase 1

An Open Label Phase 1 Dose-Escalation Study to Evaluate the Safety and Preliminary Antitumor Activity of TAK-676 with Pembrolizumab Following Radiation Therapy in the Treatment of Non-Small-Cell Lung Cancer Triple-Negative Breast Cancer or Squamous Cell Carcinoma of the Head and Neck that has Progressed on Checkpoint Inhibitors

Learn More

Phase 1

A Phase 1 bioequivalence study between the current commercial formulation & the proposed soft gel capsule formulation of talazoparib & food effect study for the proposed talazoparib soft gel capsule formulation in participants w/ advanced solid tumors

Learn More

Phase 5

A Phase Ib/II Multicenter Open-label Modular Dose-Finding and Dose Expansion Study to Explore the Safety Tolerability and Anti-tumor Activity of Trastuzumab Deruxtecan (DS-8201a T-DXd) in Combination with other Anti-cancer Agents in Patients with Metastatic HER2-positive Breast Cancer (DESTINY-Breast07)

Learn More